Michael Gray
Equibles does not estimate personal net worth.
Get an email with a short summary when X4 Pharmaceuticals, Inc publishes a filing, an earnings call transcript or a press release.
Get XFOR alertsAbout Michael Gray
Michael Gray is recorded as CEO at X4 Pharmaceuticals, Inc (XFOR). The proxy statement of X4 Pharmaceuticals, Inc reports total compensation of $1,139,822 for Michael Gray in fiscal 2019, including a base salary of $91,250. Disclosed compensation is on record for 2 fiscal years. X4 Pharmaceuticals, Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at X4 Pharmaceuticals, Inc includes Adam Raymond Craig, M.D., Ph.D. (CEO, Chairman and Board Member), Paula Ragan (CEO), Adam Craig (Chairman) and 7 others.
Affiliation history
-
Current
Company network
Leadership on record at X4 Pharmaceuticals, Inc
- Adam Raymond Craig, M.D., Ph.D. CEO, Chairman, Board Member
- Paula Ragan CEO
- Adam Craig Chairman
- Adam R. Craig Chairman
- Dr. Craig Chairman, Board Member
- David H. Kirske CFO
- David Kirske CFO
- Mr. Kirske CFO
- John Volpone COO
- Mary DiBiase, Ph.D. COO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | X4 Pharmaceuticals, Inc (XFOR) | M.B.A., C.P.A. Former President, Chief Executive Officer and Chief Financial Officer | $91,250 | $1,139,822 |
| 2018 | X4 Pharmaceuticals, Inc (XFOR) | M.B.A., C.P.A. Former President, Chief Executive Officer and Chief Financial Officer | $405,193 | $2,927,276 |
Recent activity
No call appearances or filed executive changes recorded yet.